Home › Funds › Patient Square Capital LP › MIRM

Patient Square Capital LP position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

Patient Square Capital LP reported holding 234,000 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$20.0M, representing 3.19% of its reported portfolio and ranking #8 among its reported holdings. Patient Square Capital LP has disclosed MIRM holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)234.00K sh
Reported value held$20.00M
Portfolio Weight3.19%
First reportedQ4 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Square Capital LP's MIRM position evolved

Patient Square Capital LP first disclosed a stake in MIRM in Q4 2024 at 64,900 shares (US$2.7M). The position peaked in Q2 2026 at 260,500 shares, worth US$30.5M. Across 8 filings, Patient Square Capital LP increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 234,000 shares valued at US$20.0M — a reduction of -26,500 shares quarter over quarter.. Notable position changes include a 79% increase in Q1 2025 (shares rose 13% over the following quarter), a 186% increase in Q4 2025 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 64.90K $2.68M New
Q1 2025 116.36K $5.24M Add
Q2 2025 113.46K $5.77M Reduce
Q3 2025 104.26K $7.64M Reduce
Q4 2025 298.68K $23.59M Add
Q1 2026 230.00K $21.25M Reduce
Q2 2026 260.50K $30.50M Add
Q3 2026 234.00K $20.00M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 49 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has Patient Square Capital LP held MIRM?

Patient Square Capital LP has disclosed MIRM holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Patient Square Capital LP's current position in MIRM?

As of Q3 2026, Patient Square Capital LP holds 234.00K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $20.00M, representing 3.19% of its reported portfolio and ranking #8.

Has Patient Square Capital LP been buying or selling MIRM?

In the latest 13F filing (Q3 2026), Patient Square Capital LP reduced its position in MIRM. The position peaked in Q2 2026 at 260.50K shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.